UK Research & Innovation has published this notice through Delta eSourcing
Notice Summary |
---|
Title: | GB-Swindon: UKRI - 1279 COVID Therapeutics response |
Notice type: | Competitive Contract Award Notice |
Authority: | UK Research & Innovation |
Nature of contract: | Not applicable |
Procedure: | Not applicable |
Short Description: | |
Published: | 25/01/2021 08:53 |
View Full Notice
1. Title: GB-Swindon: UKRI - 1279 COVID Therapeutics response
2. Awarding Authority:
UK Research & Innovation
Polaris House, North Star Avenue, Swindon, SN2 1FL, United Kingdom
Tel. 07590286390, Email: steven.phelps@ukri.org, URL: www.ukri.org
Contact: Steve Phelps, Attn: Steve Phelps
3. Contract Type: Services
Sub Type: Research and development services.
4. Description: Research and experimental development services. Individual Reports of manufacturing and supply of specific drug candidates (to support UK CTAP) in the therapeutic response to COVID-19
Reports to be turned around in 4 days max in batches of 2-3 over a 2 month period.
5. CPV Codes:
73100000 - Research and experimental development services.
6. NUTS Codes :
UK - UNITED KINGDOM
7. Main Site or Location of Works, Main Place of Delivery or Main Place of Performance: UNITED KINGDOM,
8. Reference Attributed by the Awarding Authority: UKRI - 1279
9. Awarded to:
Centre for Process Innovation Limited
National ID: 05002194, Wilton Centre, Wilton, Redcar, TS10 4RF, United Kingdom
Tel. +44 7717816148, Email: asif.tulah@uk-cpi.com, URL: www.ukri.org
Contact: Asif Tulah, Attn: Asif Tulah
Value Cost: 37.2
Is Awardee likely to subcontract?: No Awarded to SME?: No
10. Date of Contract Award: 13/01/2021
11. Number of Tenders Received: Not Provided
12. Other Information:
Other Information: Awarded under regulation 32 (2) (c)
therapeutic response to Covid-19
To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=563386631
TKR-2021125-PRO-17691250
Suitable for VCO: No
Period of Work Start date: 14/01/2021
Period of Work End date: 15/03/2021